Brad Nelson

Researcher

Related Research

All Cancers

A modular platform for harmonized, multiplex immune profiling of MOHCCN Gold Cohorts across Canadian institutions

Over the last two decades, researchers have discovered that long-term cancer survivors often have high numbers of immune cells within their tumours. This has led them to conclude that the immune syst...
Read More
Ovarian Cancer

Integrated immunotherapy for ovarian cancer

You've heard the saying, "It takes a village." This adage rings especially true in the battle against high-grade serous ovarian cancer (HGSC), the most common form of ovarian cancer. Just as a village...
Read More
Completed

All Cancers

Canadian Oncolytic Virus Consortium (COVCo)

In a perfect world, there would be no cancer. And if there were, patients would be able to stimulate their own immune system to destroy tumours with a virus designed to kill only cancerous cells and l...
Read More
Completed

Ovarian Cancer

Immunotherapy network (iTNT): targeting ovarian cancer

Both around the world and in Canada, teams of researchers are working hard to harness the power of a patient’s own immune system to eradicate cancer through immunotherapy. Hailed now as the four...
Read More
Completed

Multiple Cancers

BC Cancer-Princess Margaret Pilot for the Marathon of Hope Cancer Centres

In February of 2017, the Terry Fox Research Institute and two leading cancer centres in Canada – the Princess Margaret Cancer Centre in Toronto and BC Cancer in Vancouver –&...
Read More
Completed

All Cancers

Canadian oncolytic virus consortium - I

In a perfect world, there would be no cancer. And if there were, patients would be able to stimulate their own immune system to destroy tumours with a virus designed to kill only cancerous cells and l...
Read More
Completed

Ovarian Cancer

Canadian ovarian cancer research consortium

Ovarian cancer is the fifth-leading cause of cancer-related deaths in the western world. More than one in four women do not respond to standard first-line chemotherapy treatment — an alarming nu...
Read More

Related News & Events

TFRI News|November 12, 2024

Eight pan-Canadian research teams receive newly created TFRI-MOHCCN Technology Development Awards

New joint funding initiative from TFRI and the MOHCCN will support the deployment of novel technologies to accelerate precision medicine for cancer.

TFRI News|September 10, 2024

TFRI reaches record high of 20 active PPGs with nearly $20 million awarded to four teams in 2024 competition for prestigious Terry Fox New Frontiers Program Project Grants

Four Canadian research teams will receive a total of $19.8 million in new and renewal funding to advance cancer research and improve treatments as the...

Research Highlight|October 04, 2019

Early results from two studies provide insight into who may benefit from immunotherapies

Two recent studies partly funded by the TFRI are showing results that provide key insights into how immunotherapy works, and who may benefit from it.

Research Highlight|June 03, 2019

Spatial organization of immune cells within tumour microenvironment tied to survival of lung cancer patients

“The main concept we wanted to demonstrate is that the spatial organization of immune and tumour cells has a clinical impact. In other words, it’s not...

Research Highlight|June 01, 2018

Harmonizing T-cell production across multiple Canadian sites will potentially bring immunotherapy trials to more patients in more places

Ovarian cancer patients across Canada may soon have access to promising immunotherapy trials thanks to a new collaboration fostered by The Terry Fox C...

Research Highlight|May 10, 2018

TFRI-funded researchers uncover “evolutionary arms race” between cancer and immune system

A new study led by a team of TFRI-funded researchers has uncovered the mechanisms through which deadly ovarian cancer cells escape the immune system, ...

All News & Events